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Chemoenzymatic synthesis of chiral 1-benzyl-5-(hydroxymethyl)-
2-piperidone enabled by lipase AK desymmetrization of prochiral 
1,3-diol and its diacetate 
Khong Duc Thinh,a Varsha Siri Pamarthy,a Timothy Gallagher,b,* Zaher M.A. Judeha,* 
Abstract: The synthesis of (R)-1-benzyl-5-(hydroxymethyl)-2-
piperidone 1 from key synthon monoacetate (R)-3 has been 
accomplished conveniently in 6 steps with 93% ee and in 44% overall 
yield. The key step involved lipase AK desymmetrization of diol 4 to 
produce monoacetate (R)-3 in 93% ee and 93% yield. Lipase AK 
desymmetrization of diacetate 5 provided ready access to 
monoacetate (S)-3 in 93% ee and 54% yield. 
Introduction 
Chiral piperidines are embedded in many natural products and 
lead drug candidates.[1] Several chiral approaches have been 
developed for their syntheses, many of which directly start from 
chiral piperidones.[1] 2-Piperidones are key subclass of 
piperidones and are embedded in many bioactive compounds 
such as cytisine,[2] deplancheine,[3] tacamonine,[4] strynuxlines,[5] 
leuconoxine[6] and yaequinolone.[7] Cytisine (Figure 1) has 
attracted much attention as it demonstrates potent nicotinic 
agonist activity behaving as a partial agonist at α4β2 and a full 
agonist at α7.[8] Gallagher et. al. have described an efficient and 
highly convergent synthetic approach to cytisine and its 
derivatives/analogues using key synthon 1-benzyl-5-
(hydroxymethyl)-2-piperidone 1 (Figure 1).[9] This piperidine 
synthon is critical for cytisine activity.[10] 
  
 
 
 
 
 
 
 
 
 
 
Figure 1. 
Cytisine and derivatives/analogues highlighting the 2-piperidone 1 skeleton 
 
Syntheses of rac-2-piperidone 1 have been conveniently 
achieved by three approaches as depicted in i-iii, scheme 1.[11] 
However, access to the enantiopure version of 2-piperidone 1 was 
more challenging. Gallagher et al.[12] synthesis of (R)-2-piperidone 
1 relied on kinetic resolution of lactam ester 2 using α-
chymotrypsin to give an overall 16% yield after 6 steps (iv, 
Scheme 1). The major disadvantage of this approach is that 
kinetic resolution only offer up to 50% of the theoretical possible 
yield. It is evident that efficient construction of 2-piperidone 1 is 
highly desirable and ideally involving an approach that provides 
access to both enantiomers. 
 
Scheme 1. Synthesis of racemic and (R)-2-piperidone 1 
 
Our retrosynthetic analysis of 2-piperidone 1 by disconnecting 
N1-C6 bond resulted in monoacetate 3 (Figure 2). Synthesis of 
chiral monoacetate 3 could be envisioned to proceed through 
asymmetric enzymatic desymmetrization of diol 4 and its 
diacetate 5. This approach is challenging and unpredictable since 
we learned from the literature that the success of the 
desymmetrization is very dependent on the nature of the 
diol/diacetate bulky groups (acidic, basic, neutral, aliphatic, 
aromatic etc)[13] and the distance between the prochiral 
hydroxyls/acetates and the bulky groups.[14] Generally, the greater 
the distance, the lower is the enantioselectivity. Lipases have 
been successfully used for enantioselective acetylation of diols 
and hydrolysis of the corresponding meso-diacetates to give the 
two complementary enantiomeric forms of monoacetates.[13-14] 
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Figure 2. Retrosynthetic analysis of 2-piperidone 1 
Herein, we report an efficient asymmetric synthesis of 2-
piperidone 1 and key synthons monoacetates (S)- and (R)-3 
using enzymatic desymmetrization approach using commercially 
available lipases. 
Results and Discussion 
Synthesis of diol 4 and its diacetate 5  
We synthesized diol 4 and its diacetate 5 in 64% and 60% overall 
yields, respectively, as featured in scheme 2. Michael addition of 
dimethyl malonate 7 to tert-butyl acrylate 6 provided triester 8[15] 
in 90% yield. Chemoselective hydrolysis of the tert-butyl ester 
group of triester 8 using trifluoroacetic acid produced acid 9[16] in 
95% yield. Reaction of acid 9 with benzylamine provided amide 
10 in 91% yield. Reduction of amide 10 using LiBH4 provided diol 
4 as white solid in 82% yield. Acetylation of diol 4 using acetyl 
chloride produced diacetate 5 in 95% yield. 
 
Scheme 2. Synthesis of diol 4 and diacetate 5 
Desymmetrization of diol 4 through acetylation 
Lipase PS was reported as the optimal lipase for asymmetric 
desymmetrization of several 1,3-diol substrates.[17-18] We 
attempted acetylation of diol 4 with vinyl acetate in THF using 
lipase PS (from Burkholderia cepacia), lipase AK (from 
Pseudomonas fluorescens), lipase A (from Aspergillus niger), 
lipase G (from Penicillium camemberti), lipase M (from Mucor 
javanicus), CAL-B (from Candida antartica), CCL (from Candida 
rugosa) and PPL (porcine pancreatic lipase) (Table 1).[17] 
Interestingly, only lipases PS and AK catalyzed the formation of 
monoacetate 3 in excellent isolated yields (85% and 91%, 
respectively) and enantioselectivities (75% ee and 87% ee, 
respectively) (Table 1, entries 1-2). CAL-B and CCL gave poor 
yield and ee (Table 1, entries 3-4) while other lipases gave back 
the starting material unchanged. Monoacetate 3 was confirmed to 
have the (R)-configuration based on its optical rotation sign 
(section 2.4).[12] Reaction optimization was examined using 
Lipase AK because of its superior catalytic activity. 
 
 
 
 
 
 
Table 1. Screening of lipases. Enantioselective acetylation of diol 4a 
 
Entry Lipase Time (h) 
Monoacetate (R)-3 
Diacetate 
5 
Yieldb (%) Eec (%) Yieldb (%) 
1 Lipase PS 21 91 75 4 
2 Lipase AK 1 85 87 10 
3 CAL-B 21 46 0 4 
4 CCL 21 17 14 0 
a: Conditions: diol 4 (0.2 mmol), lipases (150 mg/ mmol diol 4), vinyl acetate 
(10.0 equiv), molecular sieve 4Å (10 mg), THF (3.125 mL), rt. 
b: Isolated yield 
c: Measured by HPLC: Chiralpak AD-H (hexane: i-PrOH, 95: 5), 0.9 ml/ min, 
254 nm, t1: 46.3 min, t2: 49.8 min 
 
The effect of organic solvents such as THF, MTBE, i-Pr2O, 
toluene, CHCl3, CH2Cl2, acetone and MeCN was examined (Table 
2). In all cases, the desymmetrization proceeded smoothly under 
heterogeneous condition to give monoacetate (R)-3 in excellent 
yields and enantioselectivities after 1-2 h (Table 2, entries 1-8). 
However, ether-type solvents THF, MTBE and i-Pr2O produced 
mixtures of monoacetate (R)-3 and diacetate 5 Table 2, entry 1-
3). 
 
In comparison, nonpolar and non-coordinating solvents toluene, 
CHCl3 and CH2Cl2 provided only the desired monoacetate (R)-3 
in excellent yields and comparable ees (Table 2, entries 4-6 vs 1-
3). Polar aprotic solvents acetone and MeCN also provided only 
monoacetate (R)-3 in excellent yield (91% and 96%, respectively) 
and enantioselectivity (82% and 88%, respectively) within 1 h 
(Table 2, entries 7-8). Intramolecular acyl group migration did not 
happen. HPLC analysis of monoacetate (R)-3 showed no 
racemization after storing at room temperature for 7 days. 
Next, effects of lipase loading, equivalents of vinyl acetate and 
temperature were examined using MeCN (Table 2, entries 9-16). 
Interestingly, no significant changes on the yield or ee were 
observed by varying lipase loading (Table 2, entries 8-10) or vinyl 
acetate equivalents (Table 2, entries 11-14). However, a 
decrease in the reaction temperature to 4 °C (ice-bath) and to 0 °C, 
improved the ee to 93% and 91% without compromising the 
excellent yield of 93% and 94%, respectively (Table 2, entries 15-
16). Further temperature reduction to -25 °C lead to decreased 
yield and ee as it affected lipase AK activity. In conclusion, 
enantioselective desymmetrization of diol 4 using lipase AK 
provided monoacetate (R)-3 in excellent 93% yield and 93% ee 
(Table 2, entry 15). 
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Table 2. Optimization of the enantioselective acetylation of diol 4a using lipase AK 
 
 
 
 
 
 
Entry Solvent 
Enzyme ratio 
(mg/mmol) 
Vinyl 
acetate 
(equiv) 
Temp. 
(oC) 
Time 
(min) 
Monoacetate 
(R)-3b 
Diacetate 5b Eec (%) 
1 THF 150 10 25 60 80 17 87 
2 MTBE 150 10 25 60 75 20 91 
3 i-Pr2O 150 10 25 60 65 20 78 
4 Toluene 150 10 25 120 88 0 85 
5 CHCl3 150 10 25 120 99 0 85 
6 CH2Cl2 150 10 25 100 99 0 85 
7 Acetone 150 10 25 60 91 0 82 
8 MeCN 150 10 25 45 96 0 88 
9 MeCN 250 10 25 30 95 0 87 
10 MeCN 100 10 25 120 96 0 86 
11 MeCN 150 20 25 40 96 0 87 
12 MeCN 150 15 25 60 95 0 88 
13 MeCN 150 5 25 90 94 0 88 
14 MeCN 150 3 25 120 94 0 86 
15 MeCN 150 10 4  300 93 0 93 
16 MeCN 150 10 0  360 94 0 91 
a: Conditions: diol 4 (0.2 mmol), lipase AK, vinyl acetate, molecular sieve 4Å (10 mg), solvent (3.125 mL). 
b: Isolated yield 
c: Measured by HPLC: Chiralpak AD-H (hexane: i-PrOH, 95: 5), 0.9 ml/ min, 254 nm, t1: 46.3 min, t2: 49.8 min. 
 
We carried a time-based study of desymmetrization of diol 4 to 
examine the progress of the reaction and the possibility of 
undesired racemization of monoacetate 3 under the optimal 
conditions (Table 1, entry 15). HPLC analysis of the reaction 
mixture was carried out at different time intervals and the results 
are summarized in Figure 3. It can be seen that within the first 5 
hours, the fast decrease in the amount of the starting material diol 
4 corresponded to the fast formation of monoacetate 3. No 
formation of diacetae 5 was detected during this time. However, 
as time progressed, some of the monoacetate 3 and diol 4 
converted to diacetate 5 which was obtained in 27% yield after 18 
h. The enantioselectivity of monoacetate 3 was well maintained at 
91-93% ee during the first five hours and slightly dropped to 90% 
ee after 18 h. This indicated that there was no significant 
racemisation or intramolecular acyl migration. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Time-based study of desymmetrization of diol 4 
at optimal condition 
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Desymmetrization of diacetate 5 through hydrolysis 
Enantioselective hydrolysis (or deacetylation) of diacetate 5 using 
lipase AK should give monoacetate (S)-3 since lipases display the 
same prochiral selectivity for acetylation and hydrolysis.[19] Initial 
hydrolysis experiments in phosphate buffer solution (pH 7) at 
different lipase AK loadings produced a mixture of unreacted 
starting diacetate 5, monoacetate (S)-3 and diol 4 (Table 3, 
entries 1-3). The configuration of monoacetate (S)-3 was 
confirmed by comparing its HPLC trace with monoacetate (R)-3 
and monoacetate rac-3. While reaction at lipase loading of 150 
mg/ mmol of diacetate 5 were sluggish, loading of 300 mg/ mmol 
or 600 mg/ mmol enhanced the reaction rate but still produced a 
mixture of monoacetate (S)-3 and diol 4 with low enantioselectivity 
(Table 3, entry 1-3). This reduction in selectivity may be attributed 
to the conformational mobility of lipase structure in aqueous 
media.[20] However, in organic solvents, the conformation of lipase 
is more rigid since hydrogen bonding caused by water is very 
minimal. Therefore, the use of organic co-solvents (Table 3, 
entries 4-9) was expected to increase the discrimination ability of 
lipase AK between the substrates.[21] Initial screening established 
the optimal volumetric ratio between the buffer solution and 
cosolvents to be 10:1 since higher amount of the co-solvent lead 
to lipase inactivation because of denaturation.[22] Cosolvents 
exerted strong effect on the enantioselectivity and produced 
mixtures of monoacetate (S)-3 and diol 4. While MeCN, toluene 
and THF improved the ee of monoacetate (S)-3 (87%, 82% and 
93%, respectively), acetone and i-Pr2O diminished the ee to 24% 
and 9%, respectively (Table 3, entries 4-9). Attempts to improve 
the yield of monoacetate (S)-3 on the account of diol 4 by 
conducting the reaction at buffer pH of 6.0, 6.5 and 7.5 (optimal 
working pH range of lipase AK is pH 6.0-7.5[23]) were not very 
successful (Table 3, entries 9-12). The optimal condition for 
enzymatic hydrolysis of diacetate 5 is given in table 3, entry 9.  
 
We attempted to improve the enantiopurity of monoacetate (S)-3 
by selective hydrolysis of an enantioenriched mixture of 
monoacetate (S)-3 (93% ee) using the optimal condition in table 
2, entry 15. However, no enantioselective hydrolysis was 
obtained. Instead, 50% of monoacetate (S)-3 was hydrolysed to 
diol 4 and the remaining 50% was recovered unchanged with 93% 
ee. 
 
Table 3: Screening of enzymatic hydrolysis of diacetate 5a 
 
 
 
Entry Solvent pH Enzyme (mg/mmol 
5) 
Temp. 
(oC) 
Time (h) Monoacetate 
(S)-3b (%) 
Diol 4b (%) Eec (%) 
1 H2O 7.0 150 rt 24 36 42 66 
2 H2O 7.0 300 rt 5 63 25 72 
3 H2O 7.0 600 rt 3 60 10 59 
4 H2O:MeCN 7.0 300 rt 24 46 38 87 
5 H2O:acetone 7.0 300 rt 24 56 35 24 
6 H2O:toluene 7.0 300 rt 24 49 41 82 
7 H2O:i-Pr2O 7.0 300 rt 24 56 7 9 
8 H2O:MTBE 7.0 300 rt 24 60 19 63 
9 H2O:THF 7.0 300 rt 24 54 39 93 
10 H2O:THF 6.0 300 0 24 55 33 90 
11 H2O:THF 6.5 300 0 24 53 37 90 
12 H2O:THF 7.5 300 0 24 54 32 91 
a: Conditions: diol 4 (0.2 mmol), lipase AK, vinyl acetate (10.0 equiv), molecular sieve 4Å (10 mg), solvent (3.125 mL, H2O:solvent is 10:1, v:v). 
b: Isolated yield 
c: Measured by HPLC: Chiralpak AD-H (hexane: i-PrOH, 95: 5), 0.9 ml/ min, 254 nm, t1: 46.3 min, t2: 49.8 min. 
Synthesis of chiral 1-benzyl-5-(hydroxymethyl)-2-piperidone 
1 
Tosylation of monoacetate (R)-3 followed by intramolecular amide 
alkylation using n-Bu4NHSO4 as phase transfer catalyst produced 
(R)-1-benzyl-5-(hydroxymethyl)-2-piperidone 1 in 80% yield and 
93% ee (Scheme 3). It showed optical rotation value of 𝛼𝐷
22 =
+42.5  (c, 1.0, CH2Cl2) and therefore confirming the R-
configuration assignment as (R)-1.[12] 
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Scheme 3. Synthesis of chiral 1-benzyl-5-(hydroxymethyl)-2-piperidone 1 
Conclusions 
We have achieved a practical chemoenzymatic synthesis of (R)-
1-benzyl-5-(hydroxymethyl)-2-piperidone 1 with the highest ever 
reported 44% overall yield and 93% ee in 6 steps. The synthesis 
involved intramolecular amide alkylation of the tosylated 
monoacetate (R)-3. Lipase AK desymmetrization of diol 4 
produced monoacetate (R)-3 in excellent 93% ee and 93% yield. 
Lipase AK desymmetrization of diacetate 5 produced the 
corresponding monoacetate (S)-3 in 91% ee and moderate 54% 
yield. With the availability of (R)- and (S)-piperidone 1 and (R)- 
and (S)- monoacetate 3, we anticipate their use in the synthesis 
of numerous biologically active products and chiral intermediates. 
Experimental Section 
Chemicals were purchased from Sigma-Aldrich or Alfa Aesar and used as 
received without further purification. All lipases used are in free powder 
form. Lipase PS, Lipase AK, Lipase A, Lipase G, Lipase M are from Amano 
Enzyme Inc. Lipase PPL was purchased from Sigma while CAL-B and 
CCL were purchased from Fluka. 1H NMR spectra were recorded at 300 
MHz on a Bruker Avance DPX 300. Unless stated otherwise, data refer to 
solutions in CDCl3 with TMS as an internal reference. 13C NMR spectra 
were recorded at 75.47 MHz on a Bruker Advanced DPX 300. High 
resolution mass spectra were recorded on Qstar XL MS/MS system. FTIR 
were recorded on Perkin Elmer FTIR system Spectrum BX. Analytical thin 
layer chromatography (TLC) was performed using Merck 60 F254 
precoated silica gel plate (0.2 mm thickness) and visualized using UV 
radiation (254 nm). Flash chromatography was performed using Merck 
silica gel 60 (230-400 mesh). Optical rotation values were measured on 
JASCO P-1020 polarimeter. 
Dimethyl 2-(3-(benzylamino)-3-oxopropyl)malonate 10 
Oxalyl chloride (6.25 mL, 71.7 mmol) was added drop-wise to a solution of 
carboxylic acid 9 (9.75 g, 47.8 mmol) in CH2Cl2 (60 mL) and DMF (50 µL) 
at 0 oC under inert condition. After that, the solution was allowed to warm 
up to room temperature and stirred for 1 h before removal of CH2Cl2 under 
reduced pressure. The reaction mixture was then diluted with THF (50 mL) 
and Et3N (13 mL, 95.6 mmol) and cooled to 0 oC. A solution of BnNH2 (5.74 
mL, 52 mmol) in THF (25 mL) was added drop-wise to the above solution 
under inert condition and the resulting slurry was warmed up to room 
temperature and stirred for additional 1 h. H2O (50 mL) was then added 
slowly to the slurry and the biphasic mixture produced was separated. The 
aqueous phase was extracted with CH2Cl2 (40 mL x 3). The combined 
organic phases were washed with brine, dried over MgSO4 and 
concentrated under reduced pressure. The crude residue was purified by 
column chromatography (EtOAc: hexane, 1:3) to give compound 10 (12.86 
g, yield 91%) as light yellow oil. (FTIR (KBr) νmax: 1741, 1661, 1556, 1442, 
1268, 1035, 699. 1H NMR δ: 2.23-2.35 (m, 4H), 3.53 (t, J= 6.75 Hz, 1H), 
3.75 (s, 6H), 4.44 (d, J= 15 Hz, 2H, d, J= 15 Hz, PhCH2NH), 5.83 (br s, 
1H), 7.28-7.38 (m, 5H). 13C NMR  δ: 24.5, 33.3, 43.5, 50.5, 52.6, 127.4, 
127.7, 128.6, 138.3, 169.6, 171.5.HRMS (ESI-positive mode): m/z calcd. 
for C15H19NO5 293.1263; found 316.1174 [M+Na]+. 
N-Benzyl-5-hydroxy-4-(hydroxymethyl)pentanamide 4 
To a solution of amide 10 (5.87 g, 20 mmol) in anhydrous THF (200 mL) 
and MeOH (3.8 mL) was added drop-wise a solution of LiBH4 2M in THF 
(40 mL, 80 mmol) under inert atmosphere at 0 oC. The reaction was 
allowed to warm up to room temperature, stirred for additional 1 h (TLC), 
cooled to 0 oC and was quenched by drop-wise addition of saturated 
aqueous NH4Cl solution (50 mL). The biphasic mixture was separated and 
the aqueous phase was extracted with a co-solvent of i-PrOH/CHCl3 (1/4, 
v/v) (3 x 100 mL).  The combined organic phases were washed with brine, 
dried over MgSO4, and concentrated under reduced pressure. The crude 
yellow oil was triturated with EtOAc to give diol 4 (4.03 g, 85% yield) as 
white solid, mp 90-91 oC. FTIR (KBr) νmax: 1646, 1558, 1457, 1265, 1052, 
700 cm-1. 1H NMR (CD3OD) δ: 1.56-1.67 (m, 3H), 2.28 (t, J= 7.65 Hz, 2H), 
3.53 (d, J= 5.1 Hz, 4H), 4.32 (s, 2H), 7.16-7.29 (m, 5H). 13C NMR (CD3OD) 
δ: 26.9, 36.2, 45.7, 45.8, 64.8, 129.8, 130.1, 131.2, 141.6, 177.6. HRMS 
(ESI-positive mode): m/z calcd. for C13H19NO3 237.1365; found 260.1261 
[M+Na]+. 
N-Benzyl-5-acetoxy-4-(acetoxymethyl)pentanamide 5 
To a suspension of diol 4 (1.2 g, 5 mmol) in CH2Cl2 (15 mL) was added 
Et3N (2.0 mL, 15 mmol) followed by acetyl chloride (1.1 mL, 15 mmol) at 
the ice-bath temperature. The reaction was slowly allowed to warm up to 
room temperature and stirred for 24 h (TLC). The reaction was 
concentrated and the crude residue obtained was diluted with a mixture of 
EtOAc and H2O (50 mL, 1:1 volumetric ratio). The aqueous phase was 
further extracted with EtOAc (3 x 25 mL). The combined organic extracts 
were dried over MgSO4, filtered and concentrated. The residue obtained 
was purified by column chromatography (hexane: EtOAc, 1:1) to give 
diacetate 5 (1.48 g, 92% yield) as yellow oil. FTIR (KBr) νmax: 1741, 1655, 
1558, 1248, 1045. 1H NMR δ: 1.70-1.78 (m, 2H), 1.97-2.08 (m, 1H), 2.04 
(s, 6H), 2.27-2.33 (t, J= 7.95 Hz, 2H), 4.05-4.07 (d, J=  6Hz, 4H), 4.41-4.43 
(d, J= 5.4 Hz, 2H), 6.08 (br s, 1H), 7.26-7.37 (m, 5H). 13C NMR δ: 21.0, 
24.4, 33.6, 37.1, 43.8, 63.9, 127.6, 127.8, 128.7, 138.2, 171.2, 172.1. 
HRMS (ESI-positive mode): m/z calcd. for C17H23NO5 321.1576; found 
344.1481 [M+Na]+. 
Enantioselective acetylation of diol 4 under optimal condition 
Lipase AK (30 mg, 150 mg/ mmol) was added to a suspension of diol 4 (48 
mg, 0.2 mmol) and molecular sieve 4Å (10 mg) in MeCN (3.1 mL) at 4 oC 
under inert condition. The mixture was stirred for 15 min, vinyl acetate (190 
µL, 2 mmol) was added and then further stirred for 4-5 h at 4 oC. The 
reaction mixture was filtrated, evaporated and purified by column 
chromatography (EtOAc: hexane, 5:1) to give monoacetate (R)-3 (52 mg, 
93% yield) as colorless oil, [𝛼]𝐷
22 − 2.1 (c, 0.11, CH2Cl2). FTIR (KBr) νmax: 
1737, 1659, 1556, 1269, 1037, 702 cm-1. 1H NMR δ: 1.53-1.79 (m, 3H), 
1.96 (s, 3H), 2.12-2.32 (m, 2H), 3.47-3.49 (d, J= 4.5 Hz, 2H), 4.00-4.02 (d, 
J= 4.8 Hz, 2H), 4.35 (d, J= 5.7 Hz, 2H), 6.17 (br s, 1H), 7.17-7.28 (m, 5H). 
13C NMR δ: 20.9, 23.3, 33.6, 40.2, 43.7, 61.7, 64.5, 127.6, 127.8, 128.7, 
138.1, 171.6, 173. HRMS (ESI-positive mode): m/z calcd. for C15H21NO4 
279.1471; found 302.1373 [M+Na]+. HPLC: Chiralpak AD-H (hexane: 
iPrOH, 95: 5), 0.9 ml/ min, 254 nm, t1: 46.3 min, t2: 49.8 min (93% ee).  
HO
AcO
CONHBn N
Bn
OH
O
a,b
Reagents and conditions: (a) TsCl, DMAP, Et3N, DCM, 0
oC -rt; 12 h; (b) n-Bu4NHSO4, NaOH, K2CO3, PhMe,
ref lux, 2-3 h
80% yield
93% ee
R-3 R-1
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Enantioselective hydrolysis of diacetate 5 under optimal condition  
To a solution of diacetate 5 (64 mg, 0.2 mmol) in buffer pH 7 (12.5 mL) 
and THF (1.25 mL) was added lipase AK (90 mg, 450 mg/ mmol) at room 
temperature. The reaction was stirred for 11 h and then extracted with 
CH2Cl2 (10 mL x 3). The organic phase was washed with brine, dried over 
MgSO4, filtrated and evaporated under reduced pressure. The crude 
mixture was purified by column chromatography (hexane: EtOAc, 1:1) to 
give diol 4 (18 mg, 39% yield) and monoacetate (S)-3 (48 mg, 51% yield) 
as colorless oils. [𝛼]𝐷
22 + 2.3 (c, 0.15, CH2Cl2).  HPLC: Chiralpak AD-H 
(hexane: iPrOH, 95: 5), 0.9 ml/ min, 254 nm, t1: 46.3 min, t2: 49.8 min (93% 
ee). 
 (R)-1-benzyl-4-(hydroxymethyl)piperidin-2-one 1 
To a solution of (R)-3 (280 mg, 1 mmol) in CH2Cl2 (10 mL) was added 
consecutively Et3N (270 µL, 2 mmol) and DMAP (12.2 mg, 0.1 mmol) at 0 
oC. A solution of p-toluenesulfonyl chloride (210 mg, 1.1 mmol) in CH2Cl2 
(5 mL) was then added drop-wise to the above solution while maintaining 
the temperature at 0 oC. The reaction mixture was stirred for 12 h while 
allowed to warm up to room temperature. It was then washed with H2O (2 
x 25 mL) and brine solution (25 mL). The CH2Cl2 phase was dried over 
MgSO4, filtered, concentrated and the crude residue was re-dissolved in 
toluene (10 mL). n-Bu4NHSO4 (34 mg, 0.1 mmol), NaOH (40 mg, 1.0 
mmol), and K2CO3 (415 mg, 3.0 mmol) were consecutively added to the 
toluene solution and the resulting mixture was heated at 90 oC for 2 h until 
the complete consumption of the tosylate starting material. The mixture 
was then filtered, diluted with EtOAc and the organic layer was washed 
with H2O (25 mL x 2), brine (25 mL), dried over MgSO4, filtered and 
concentrated. The crude residue obtained was purified by column 
chromatography (EtOAc: Hexane = 3:1) to give 2-piperidone 1 (186 mg, 
85% yield) as viscous oil. 𝛼𝐷
22 + 43 (c, 1.0, CH2Cl2). 1H NMR δ: 1.46-1.52 
(m,1H), 1.79-1.89 (m, 1H), 1.90-2.05 (m, 1H), 2.39-2.51 (m, 2H), 2.99 (t, 
J= 11.25 Hz, 1H), 3.27-3.33 (m, 1H), 3.40-3.46 (m, 1H), 3.51-3.56 (m, 1H), 
4.56 (q, J= 14.7 Hz, 2H), 7.20-7.33 (m, 5H). 13C NMR δ: 23.8, 31.2, 36.4, 
49.9, 50.4, 64.3, 127.5, 128.0, 136.9, 170.2. HRMS (ESI, positive mode) 
m/z calcd. for C13H17NO2 219.1259, found 220.1329 [M+H]+.[12, 24] 
Literature values for (R)-1[12]: 1H NMR: (400 MHz, CDCl3) : 1.51 – 1.61 
(1H, m), 1.87–1.93 (1H, m), 2.00 – 2.09 (1H, m), 2.45 (1H, ddd, J = 18.0, 
11.0, 6.5), 2.58 (1H, ddd, J = 18.0, 6.5, 3.5), 3.02 (1H, dd, J = 12.0, 9.5), 
3.30 (1H, ddd, J = 12.0, 5.5, 1.5), 3.46 – 3.53 (2H, m), 4.60 (2H, s), 7.23 – 
7.35 (5H, m, ArCH x 5). 13C NMR: (100 MHz, CDCl3) : 23.8 (CH2), 31.2 
(CH2), 36.5 (CH), 49.7 (CH2), 50.4 (CH2), 64.5 (CH2), 127.4, 128.3, 128.7 
(ArCH x 5), 137.1 (ipso-Ph), 170.0 (C=O). 
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